130 related articles for article (PubMed ID: 34596182)
21. Synthesis of Sulfotyrosine-Containing Peptides by Incorporating Fluorosulfated Tyrosine Using an Fmoc-Based Solid-Phase Strategy.
Chen W; Dong J; Li S; Liu Y; Wang Y; Yoon L; Wu P; Sharpless KB; Kelly JW
Angew Chem Int Ed Engl; 2016 Jan; 55(5):1835-8. PubMed ID: 26696445
[TBL] [Abstract][Full Text] [Related]
22. Thrombin-Inhibiting Anticoagulant Liposomes: Development and Characterization.
Endreas W; Brüßler J; Vornicescu D; Keusgen M; Bakowsky U; Steinmetzer T
ChemMedChem; 2016 Feb; 11(3):340-9. PubMed ID: 26662675
[TBL] [Abstract][Full Text] [Related]
23. Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin.
Tabernero L; Chang CY; Ohringer SL; Lau WF; Iwanowicz EJ; Han WC; Wang TC; Seiler SM; Roberts DG; Sack JS
J Mol Biol; 1995 Feb; 246(1):14-20. PubMed ID: 7853394
[TBL] [Abstract][Full Text] [Related]
24. Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.
Brandstetter H; Turk D; Hoeffken HW; Grosse D; Stürzebecher J; Martin PD; Edwards BF; Bode W
J Mol Biol; 1992 Aug; 226(4):1085-99. PubMed ID: 1518046
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of heparin-like antithrombotics having perphosphorylated thrombin binding domains.
Buijsman RC; Basten JE; Dreef-Tromp CM; van der Marel GA; van Boeckel CA; van Boom JH
Bioorg Med Chem; 1999 Sep; 7(9):1881-90. PubMed ID: 10530936
[TBL] [Abstract][Full Text] [Related]
26. Inhibitor binding to thrombin: x-ray crystallographic studies.
Banner DW; Hadváry P
Adv Exp Med Biol; 1993; 340():27-33. PubMed ID: 8154341
[No Abstract] [Full Text] [Related]
27. Crystal structure of thrombin in complex with S-variegin: insights of a novel mechanism of inhibition and design of tunable thrombin inhibitors.
Koh CY; Kumar S; Kazimirova M; Nuttall PA; Radhakrishnan UP; Kim S; Jagadeeswaran P; Imamura T; Mizuguchi J; Iwanaga S; Swaminathan K; Kini RM
PLoS One; 2011; 6(10):e26367. PubMed ID: 22053189
[TBL] [Abstract][Full Text] [Related]
28. Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles.
Isaacs RC; Solinsky MG; Cutrona KJ; Newton CL; Naylor-Olsen AM; McMasters DR; Krueger JA; Lewis SD; Lucas BJ; Kuo LC; Yan Y; Lynch JJ; Lyle EA
Bioorg Med Chem Lett; 2008 Mar; 18(6):2062-6. PubMed ID: 18291642
[TBL] [Abstract][Full Text] [Related]
29. Toward a framework for sulfoproteomics: Synthesis and characterization of sulfotyrosine-containing peptides.
Seibert C; Sakmar TP
Biopolymers; 2008; 90(3):459-77. PubMed ID: 17680702
[TBL] [Abstract][Full Text] [Related]
30. Structure-activity relationships of inhibitors derived from 3-amidinophenylalanine.
Stürzebecher J; Prasa D; Wikström P; Vieweg H
J Enzyme Inhib; 1995; 9(1):87-99. PubMed ID: 8568569
[TBL] [Abstract][Full Text] [Related]
31. Liporetro-D-peptides - a novel class of highly selective thrombin inhibitors.
Poyarkov AA; Poyarkova SA; Smirnova IV; Kukhar VP
Thromb Res; 2012 Apr; 129(4):e97-105. PubMed ID: 22079445
[TBL] [Abstract][Full Text] [Related]
32. A fluorine scan of the phenylamidinium needle of tricyclic thrombin inhibitors: effects of fluorine substitution on pKa and binding affinity and evidence for intermolecular C-F...CN interactions.
Olsen J; Seiler P; Wagner B; Fischer H; Tschopp T; Obst-Sander U; Banner DW; Kansy M; Müller K; Diederich F
Org Biomol Chem; 2004 May; 2(9):1339-52. PubMed ID: 15105924
[TBL] [Abstract][Full Text] [Related]
33. X-ray crystal structures of thrombin in complex with D-Phe-Pro-Arg and with small benzamidine- and arginine-based "non-peptidic" inhibitors.
Bode W
Adv Exp Med Biol; 1993; 340():15-26. PubMed ID: 8154332
[No Abstract] [Full Text] [Related]
34. Thrombin inhibitors identified by computer-assisted multiparameter design.
Riester D; Wirsching F; Salinas G; Keller M; Gebinoga M; Kamphausen S; Merkwirth C; Goetz R; Wiesenfeldt M; Stürzebecher J; Bode W; Friedrich R; Thürk M; Schwienhorst A
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8597-602. PubMed ID: 15937115
[TBL] [Abstract][Full Text] [Related]
35. Synthetic low-molecular weight thrombin inhibitors: the ideal antithrombotic drug? An introduction.
Stürzebecher J; Meier J
J Enzyme Inhib; 1995; 9(1):1-2. PubMed ID: 8568561
[No Abstract] [Full Text] [Related]
36. Determination of the sites of tyrosine O-sulfation in peptides and proteins.
Yu Y; Hoffhines AJ; Moore KL; Leary JA
Nat Methods; 2007 Jul; 4(7):583-8. PubMed ID: 17558413
[TBL] [Abstract][Full Text] [Related]
37. Identification and molecular mechanism of antithrombotic peptides from oyster proteins released in simulated gastro-intestinal digestion.
Chen H; Cheng S; Fan F; Tu M; Xu Z; Du M
Food Funct; 2019 Sep; 10(9):5426-5435. PubMed ID: 31402368
[TBL] [Abstract][Full Text] [Related]
38. Engineering of a Small Protein Scaffold To Recognize Sulfotyrosine with High Specificity.
Lawrie J; Waldrop S; Morozov A; Niu W; Guo J
ACS Chem Biol; 2021 Aug; 16(8):1508-1517. PubMed ID: 34251168
[TBL] [Abstract][Full Text] [Related]
39. Phosphate modulates receptor sulfotyrosine recognition by the chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2).
Ludeman JP; Nazari-Robati M; Wilkinson BL; Huang C; Payne RJ; Stone MJ
Org Biomol Chem; 2015 Feb; 13(7):2162-9. PubMed ID: 25536525
[TBL] [Abstract][Full Text] [Related]
40. Structural and Functional Characterization of Hirudin P6 Derived Novel Bivalent Thrombin Inhibitors - Studying the Effect of Linker Length and Glycosylation on Their Function.
Shabareesh P; Kaur KJ
Chem Biol Drug Des; 2016 Jul; 88(1):129-41. PubMed ID: 26850929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
